Welcome to our dedicated page for RLI SEC filings (Ticker: RLI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Parsing a specialty insurer’s disclosures isn’t easy. RLI’s 10-K alone buries combined-ratio shifts, catastrophe reserve updates, and surety bond loss trends deep inside actuarial tables. If you have ever searched "RLI SEC filings explained simply" or asked, "Where can I see RLI insider trading Form 4 transactions?", you already know how time-consuming it is to locate the right numbers.
Stock Titan fixes that. Our AI reviews every RLI quarterly earnings report 10-Q filing, RLI annual report 10-K simplified, and RLI 8-K material events explained the moment they post to EDGAR. You’ll get plain-language summaries, side-by-side trend charts, and real-time alerts for RLI Form 4 insider transactions real-time. Need the proxy? Our engine highlights board fees and RLI proxy statement executive compensation metrics without digging through appendices.
Use these insights to:
- Monitor combined ratio moves before earnings calls
- Compare surety bond loss development across quarters
- Track RLI executive stock transactions Form 4 ahead of dividend changes
RLI Corp reported an insider equity award. Chief Operating Officer Jennifer L. Klobnak acquired a stock option covering 8,125 shares at an exercise price of $58.66 per share on 11/03/2025. The option vests in 20% increments annually, beginning one year from the grant date, and expires on 11/03/2033. The filing shows the option was acquired at a price of $0 and is held directly.
RLI Corp (RLI) reported a Form 4 showing its Chief Executive Officer received a stock option grant. On 11/03/2025, the CEO was granted options to purchase 15,000 shares of common stock at an exercise price of $58.66 per share.
The options vest in 20% annual increments, beginning one year from the grant date on 11/03/2026, and expire on 11/03/2033. Following the transaction, 15,000 derivative securities were beneficially owned in direct form.
RLI Corp reported an insider equity award on a Form 4. An officer (Vice President, Controller) acquired a stock option covering 1,250 shares at an exercise price of $58.66 on November 3, 2025.
The option begins to vest on November 3, 2026, with 20% of the grant exercisable each year thereafter, and expires on November 3, 2033. Following the grant, 1,250 derivative securities were beneficially owned, held directly.
RLI Corp reported an insider equity award on Form 4. Chief Legal Officer Jeffrey D. Fick received a grant of 3,750 stock options on 11/03/2025 with an exercise price of $58.66 per share. The options cover 3,750 shares of common stock, begin to vest at 20% per year starting 11/03/2026, and carry an expiration date of 11/03/2033. Following the grant, 3,750 derivative securities were beneficially owned directly.
RLI Corp reported an insider equity award. The company’s Chief Financial Officer received a stock option grant for 6,250 shares at an exercise price of $58.66 on 11/03/2025.
The option vests in 20% increments each year starting 11/03/2026 and expires on 11/03/2033. After the grant, 6,250 derivative securities were beneficially owned, held directly.
RLI Corp (RLI) reported an insider transaction by a director. On
Following the transaction, the director beneficially owned 25,278.657 shares held indirectly through a Directors' Trust. The filing notes the shares were allocated under the RLI Corp. Non-Employee Directors Deferred Compensation Plan, with figures adjusted for a 2-for-1 stock split effective
RLI Corp reported an insider transaction on a Form 4. A director received an allocation of 445.217 shares of common stock at $58.96 on 10/31/2025 (transaction code J). The holdings are reported as indirect through a Directors' Trust, bringing the amount beneficially owned after the transaction to 6,172.425 shares.
The filing notes the shares were allocated under the RLI Corp. Non-Employee Directors Deferred Compensation Plan, with figures adjusted for a 2-for-1 stock split on 01/15/25, and the balance reflects dividend reinvestment.
RLI Corp (RLI) reported an insider transaction by a director. On 10/31/2025, the reporting person recorded an indirect acquisition of 121.905 shares of common stock at $58.96 per share (transaction code J), allocated pursuant to the RLI Corp. Non-Employee Directors Deferred Compensation Plan. Following the transaction, beneficial ownership stood at 19,732.393 shares held indirectly via a Directors' Trust. The filing notes amounts were adjusted for a 2-for-1 stock split on 01/15/25 and that ownership reflects dividend reinvestment.
RLI Corp. filed an 8-K announcing it held an analyst conference call regarding its third quarter 2025 results on October 21, 2025. The company furnished the call transcript as Exhibit 99.1, which is incorporated by reference.
The filing states that furnishing the transcript is not intended to indicate it is required under Regulation FD or that it contains material investor information beyond what is publicly available. The company also notes it does not assume an obligation to update the information.
RLI Corp. reported stronger Q3 2025 results. Consolidated revenue reached $509.3 million (up from $470.0 million), driven by higher net premiums earned of $407.7 million and net investment income of $41.3 million. Net earnings rose to $124.6 million with diluted EPS of $1.35, helped by $18.3 million of realized gains and $42.0 million of unrealized gains on equity securities.
Total expenses were $353.6 million as loss costs declined year over year. For the first nine months, net earnings were $312.2 million and operating cash flow was $457.5 million. Prior-year reserve development was favorable by $74 million year to date, notably in commercial excess liability, marine, surety, commercial property, general liability and mortgage reinsurance; commercial transportation experienced adverse auto liability development.
On the balance sheet, total assets were $6.25 billion and shareholders’ equity was $1.87 billion. The available-for-sale fixed income portfolio was $3.54 billion at fair value, and equity securities were $878.9 million. The company effected a two-for-one stock split on January 15, 2025. Shares outstanding were 91,837,835 as of October 14, 2025.